(Q28167649)

English

Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications

scientific article (publication date: March 2004)

In more languages

Statements

scholarly article

0 references

Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications (English)

0 references

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

S H Song

1

0 references

P M Brown

2

0 references

language of work or name

0 references

publication date

March 2004

0 references

Diabetic Medicine

0 references

21

0 references

3

0 references

238-45

0 references

Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

Cardiovascular disease risk profiles.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

Comparative accuracy of cardiovascular risk prediction methods in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

Lipid lowering in patients with diabetes mellitus: what coronary heart disease risk threshold should be used?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

Greater effect of diabetes on LDL size in women than in men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin-treated diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

Lipid-lowering therapy for the primary prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2004.01116.X

21 January 2018

Identifiers

10.1111/J.1464-5491.2004.01116.X

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28167649&oldid=1630088749"